Handelsinvest Investeringsforvaltning »

Blueprint Medicines shares owned by Handelsinvest Investeringsforvaltning

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Handelsinvest Investeringsforvaltning from 13F filings

Historical chart of Handelsinvest Investeringsforvaltning investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Handelsinvest Investeringsforvaltning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Handelsinvest Investeringsforvaltning

Quarter filed Position value Share count Share price at filing
2024-03-31 $368k 3.9k 94.94
2023-12-31 $543k 5.9k 92.22

More positions owned by Handelsinvest Investeringsforvaltning

Microsoft Corp Common Stock (MSFT)
NVIDIA Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Alphabet Common Stock (GOOGL)
Meta Platforms Common Stock (META)
JPMorgan Chase & Co Common Stock (JPM)
Eli Lilly & Co Common Stock (LLY)
Broadcom Common Stock (AVGO)
Visa Common Stock (V)
Mastercard Common Stock (MA)
UnitedHealth Group Common Stock (UNH)
Procter & Gamble Co/The Common Stock (PG)
Merck & Co Common Stock (MRK)
Alphabet Common Stock (GOOG)

View all positions for Handelsinvest Investeringsforvaltning

Top funds holding Blueprint Medicines

Vanguard Group
T. Rowe Price Associates
Wellington Management Company
William Blair Investment Management
Jpmorgan Chase & Co
Lord, Abbett & Co
Alliancebernstein
Brown Advisory Holdings Incorporated
Avidity Partners Management
Norges Bank Investment Management
Goldman Sachs Group
Charles Schwab Investment Management
Emerald Advisers
Point72 Asset Management
Bank of America Corporation

View all funds holding Blueprint Medicines